Testing a Unique HDL Mimetic Peptide to Reverse ApoE4 Lipidation Deficiency and Alzheimer's Neuropathology
测试独特的 HDL 模拟肽以逆转 ApoE4 脂化缺陷和阿尔茨海默病神经病理学
基本信息
- 批准号:9306478
- 负责人:
- 金额:$ 18.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:ATP binding cassette transporter 1ATP-Binding Cassette TransportersAbeta clearanceAbeta synthesisAdverse effectsAffectAgeAgonistAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAmino AcidsAmyloidAmyloid beta-ProteinAnimal ExperimentsAnimal ModelApolipoprotein A-IApolipoprotein EApolipoproteinsAstrocytesBehaviorBehavior assessmentBehavioralBexaroteneBiochemicalBlood - brain barrier anatomyBlood VesselsBrainBrain DiseasesCardiovascular DiseasesCell modelCerebrumCholesterolClinicalClinical TrialsDataDevelopmentDiseaseExhibitsFamilyFatty LiverGenesGeneticGenotypeGoalsHigh Density LipoproteinsHumanHyperlipidemiaImpaired cognitionLate Onset Alzheimer DiseaseLeadLipidsLipoproteinsLiver X ReceptorMediatingMetabolismMicrogliaMolecularMusNeurodegenerative DisordersNeurofibrillary TanglesNeurogliaPathogenicityPathologicPathologyPathway interactionsPatientsPeptidesPharmacologyPhenylalaninePlasmaPositioning AttributePropertyProtein IsoformsProteinsRXRRXRA geneResearchResearch Project GrantsSafetySenile PlaquesSequence HomologyStructureTestingTherapeuticTherapeutic AgentsUp-Regulationabeta accumulationabeta depositionapolipoprotein E-3apolipoprotein E-4basebeta amyloid pathologycognitive functiondesigneffective therapyexperienceextracellulargain of functiongenetic risk factorhyperphosphorylated tauimprovedinnovationlipid metabolismmouse modelneuropathologynovel therapeutic interventionoverexpressionpeptidomimeticspreclinical studypreventsexsynthetic peptidetau Proteins
项目摘要
PROJECT SUMMARY
Inheritance of the apolipoprotein E4 (apoE4) gene is the strongest genetic risk factor identified to date for late
onset Alzheimer’s disease (AD). Although the mechanisms by which apoE4 affects the development of AD are
not completely understood, compelling evidence indicates that the pathogenic effects of apoE4 are mediated
by lipid-related pathways. Compared with the more common apoE3 isoform, apoE4 exhibits deficiency in
lipidation and formation of high density lipoproteins (HDL) in the brain. Genetic and pharmacological
manipulations of apoE lipidation/HDL formation pathways have been shown to modulate cognitive function and
neuropathology in animal models of AD. However, adverse side effects associated with those treatments are of
significant concern. In the present proposal, we attempt to repurpose a unique, well characterized, and
clinically tested HDL mimetic peptide to reverse apoE4 lipidation deficiency and AD-related neuropathology.
This small synthetic peptide consists of 18 amino acids and has no direct sequence homology to natural
proteins but mimics the unique lipid-interacting structure contained in HDL-associated apolipoproteins.
Previous studies have demonstrated that this peptide possesses vascular protective properties as HDL. It has
advanced into early human clinical trials for cardiovascular disease and showed no safety concerns. In
preliminary studies, we have found that this peptide promotes cellular cholesterol efflux, enhances apoE
secretion and lipidation from astrocytes and microglia, and counteracts amyloid β (Aβ)-induced suppression on
apoE secretion and lipidation by glial cells. In addition, this peptide inhibits Aβ aggregation, promotes the
transport of Aβ across a cellular model of human blood-brain barrier (BBB), and efficiently penetrates the BBB
in mice. Thus, we hypothesize that treatment with this unique peptide can rescue brain apoE4 lipidation and
functional deficits and mitigate apoE4-associated neuropathology in AD. This hypothesis will be tested by two
specific aims in human apoE4-targeted replacement (TR) mice, which recapitulate functional deficits of apoE4
carriers in humans, compared with human apoE3-TR mice in the absence or presence of Aβ pathology.
Positive results from this preclinical study are expected to have a significant overall impact in the research field
of AD as this project will provide a proof of concept for developing innovative HDL-based therapeutic
approaches targeting apoE4 pathological mechanisms.
项目摘要
载脂蛋白E4(apoE 4)基因的遗传是迄今为止发现的晚期乳腺癌最强的遗传风险因素。
阿尔茨海默病(AD)。虽然apoE 4影响AD发生的机制是
尽管尚未完全了解,但有令人信服的证据表明,apoE 4的致病作用是介导的,
通过脂质相关的途径。与更常见的apoE 3亚型相比,apoE 4在以下方面表现出缺陷:
脂质化和脑中高密度脂蛋白(HDL)的形成。遗传和药理学
apoE脂化/HDL形成途径的操作已显示调节认知功能,
AD动物模型中的神经病理学。然而,与这些治疗相关的不良副作用是
重大关切。在目前的建议中,我们试图重新利用一个独特的,特点鲜明的,
临床测试的HDL模拟肽逆转apoE 4脂质化缺陷和AD相关的神经病理学。
这种小的合成肽由18个氨基酸组成,与天然的肽没有直接的序列同源性。
蛋白质,但模仿独特的脂质相互作用的结构中包含的HDL相关载脂蛋白。
以前的研究已经证明,这种肽具有血管保护特性的HDL。它有
进入心血管疾病的早期人体临床试验,没有显示出安全性问题。在
初步研究,我们发现这种肽促进细胞胆固醇流出,增强apoE,
从星形胶质细胞和小胶质细胞的分泌和脂化,并抵消淀粉样蛋白β(Aβ)诱导的抑制,
胶质细胞的apoE分泌和脂化。此外,这种肽抑制Aβ聚集,促进A β的形成,
Aβ转运穿过人血脑屏障(BBB)的细胞模型,并有效穿透BBB
对小鼠因此,我们假设用这种独特的肽治疗可以挽救脑apoE 4脂化,
功能缺陷和减轻AD中apoE 4相关的神经病理学。这一假设将由两个
在人apoE 4靶向替代(TR)小鼠中的特定目的,重现apoE 4的功能缺陷
携带者在人类中,与人类apoE 3-TR小鼠在不存在或存在Aβ病理学的情况下进行比较。
这项临床前研究的积极结果预计将在研究领域产生重大的整体影响
因为该项目将为开发创新的基于HDL的治疗药物提供概念证明
靶向apoE 4病理机制的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LING LI其他文献
LING LI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LING LI', 18)}}的其他基金
Impact of Mitochondrial Lipidomic Dynamics and its Interaction with APOE Isoforms on Brain Aging and Alzheimers Disease
线粒体脂质组动力学及其与 APOE 亚型的相互作用对脑衰老和阿尔茨海默病的影响
- 批准号:
10645610 - 财政年份:2023
- 资助金额:
$ 18.98万 - 项目类别:
Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance
蛋白精氨酸甲基转移酶 9 在急性髓系白血病维持中的作用
- 批准号:
10348138 - 财政年份:2020
- 资助金额:
$ 18.98万 - 项目类别:
Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance
蛋白精氨酸甲基转移酶 9 在急性髓系白血病维持中的作用
- 批准号:
10580742 - 财政年份:2020
- 资助金额:
$ 18.98万 - 项目类别:
Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance
蛋白精氨酸甲基转移酶 9 在急性髓系白血病维持中的作用
- 批准号:
10094213 - 财政年份:2020
- 资助金额:
$ 18.98万 - 项目类别:
Targeting protein acetylation as a therapeutic approach for MDS
靶向蛋白质乙酰化作为 MDS 的治疗方法
- 批准号:
10379453 - 财政年份:2018
- 资助金额:
$ 18.98万 - 项目类别:
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3
研究职业发展:SIRT1 脱乙酰酶在维持 FLT3 中的作用
- 批准号:
9148427 - 财政年份:2015
- 资助金额:
$ 18.98万 - 项目类别:
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3
研究职业发展:SIRT1 脱乙酰酶在维持 FLT3 中的作用
- 批准号:
9151696 - 财政年份:2015
- 资助金额:
$ 18.98万 - 项目类别:
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3
研究职业发展:SIRT1 脱乙酰酶在维持 FLT3 中的作用
- 批准号:
8876619 - 财政年份:2014
- 资助金额:
$ 18.98万 - 项目类别:
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3
研究职业发展:SIRT1 脱乙酰酶在维持 FLT3 中的作用
- 批准号:
8679747 - 财政年份:2014
- 资助金额:
$ 18.98万 - 项目类别:
Protective Mechanisms of Statins in Alzheimer's Disease
他汀类药物对阿尔茨海默病的保护机制
- 批准号:
7438967 - 财政年份:2008
- 资助金额:
$ 18.98万 - 项目类别:
相似海外基金
ATP Binding Cassette Transporters in Health and Disease
健康和疾病中的 ATP 结合盒转运蛋白
- 批准号:
10390366 - 财政年份:2021
- 资助金额:
$ 18.98万 - 项目类别:
ATP Binding Cassette Transporters in Health and Disease
健康和疾病中的 ATP 结合盒转运蛋白
- 批准号:
10237095 - 财政年份:2021
- 资助金额:
$ 18.98万 - 项目类别:
ATP Binding Cassette Transporters in Health and Disease
健康和疾病中的 ATP 结合盒转运蛋白
- 批准号:
10552563 - 财政年份:2021
- 资助金额:
$ 18.98万 - 项目类别:
Photosensitizing Nanoconstructs for Regulation of ATP-Binding Cassette Transporters in the Brain
用于调节大脑中 ATP 结合盒转运蛋白的光敏纳米结构
- 批准号:
2030253 - 财政年份:2020
- 资助金额:
$ 18.98万 - 项目类别:
Standard Grant
Structural and functional studies of iron uptake ATP-binding cassette transporters (ABC transporters) in Gram-negative bacteria
革兰氏阴性菌中铁摄取 ATP 结合盒转运蛋白(ABC 转运蛋白)的结构和功能研究
- 批准号:
20K22561 - 财政年份:2020
- 资助金额:
$ 18.98万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Investigating the mechanism of polysaccharide recognition and export by bacterial ATP-binding cassette transporters
研究细菌 ATP 结合盒转运蛋白识别和输出多糖的机制
- 批准号:
489384-2016 - 财政年份:2018
- 资助金额:
$ 18.98万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Investigating the mechanism of polysaccharide recognition and export by bacterial ATP-binding cassette transporters
研究细菌 ATP 结合盒转运蛋白识别和输出多糖的机制
- 批准号:
489384-2016 - 财政年份:2017
- 资助金额:
$ 18.98万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Investigating the mechanism of polysaccharide recognition and export by bacterial ATP-binding cassette transporters
研究细菌 ATP 结合盒转运蛋白识别和输出多糖的机制
- 批准号:
489384-2016 - 财政年份:2016
- 资助金额:
$ 18.98万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
The Mechanism of ATP Binding Cassette Transporters
ATP 结合盒转运蛋白的机制
- 批准号:
318360 - 财政年份:2014
- 资助金额:
$ 18.98万 - 项目类别:
Fellowship Programs
Heat shock protein 27 attenuates foam cell formation by enhancing cholesterol efflux via the ATP-binding cassette transporters A1
热休克蛋白 27 通过 ATP 结合盒转运蛋白 A1 增强胆固醇流出,从而减弱泡沫细胞形成
- 批准号:
304334 - 财政年份:2014
- 资助金额:
$ 18.98万 - 项目类别:














{{item.name}}会员




